nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—Hydrochlorothiazide—nephrolithiasis	0.269	1	CrCtD
Bendroflumethiazide—Thiazides—Hydrochlorothiazide—nephrolithiasis	0.218	0.635	CiPCiCtD
Bendroflumethiazide—Increased Diuresis—Hydrochlorothiazide—nephrolithiasis	0.125	0.365	CiPCiCtD
Bendroflumethiazide—KCNMA1—Hydrochlorothiazide—nephrolithiasis	0.0644	0.361	CbGbCtD
Bendroflumethiazide—SLC12A3—Hydrochlorothiazide—nephrolithiasis	0.0411	0.231	CbGbCtD
Bendroflumethiazide—Hydroflumethiazide—Hydrochlorothiazide—nephrolithiasis	0.0404	0.238	CrCrCtD
Bendroflumethiazide—Cyclothiazide—Hydrochlorothiazide—nephrolithiasis	0.033	0.195	CrCrCtD
Bendroflumethiazide—Polythiazide—Hydrochlorothiazide—nephrolithiasis	0.033	0.195	CrCrCtD
Bendroflumethiazide—Benzthiazide—Hydrochlorothiazide—nephrolithiasis	0.033	0.195	CrCrCtD
Bendroflumethiazide—Trichlormethiazide—Hydrochlorothiazide—nephrolithiasis	0.0303	0.179	CrCrCtD
Bendroflumethiazide—CA1—Hydrochlorothiazide—nephrolithiasis	0.0259	0.145	CbGbCtD
Bendroflumethiazide—CA4—Hydrochlorothiazide—nephrolithiasis	0.0243	0.137	CbGbCtD
Bendroflumethiazide—CA2—Hydrochlorothiazide—nephrolithiasis	0.0224	0.126	CbGbCtD
Bendroflumethiazide—SLC12A3—loop of Henle—nephrolithiasis	0.0075	0.385	CbGeAlD
Bendroflumethiazide—SLC12A3—collecting duct of renal tubule—nephrolithiasis	0.00426	0.219	CbGeAlD
Bendroflumethiazide—SLC12A3—nephron—nephrolithiasis	0.0019	0.0974	CbGeAlD
Bendroflumethiazide—CA4—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00167	0.13	CbGpPWpGaD
Bendroflumethiazide—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00161	0.124	CbGpPWpGaD
Bendroflumethiazide—CA1—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00154	0.119	CbGpPWpGaD
Bendroflumethiazide—CA2—collecting duct of renal tubule—nephrolithiasis	0.00145	0.0745	CbGeAlD
Bendroflumethiazide—Gastric irritation—Hydrochlorothiazide—nephrolithiasis	0.00113	0.149	CcSEcCtD
Bendroflumethiazide—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.000834	0.11	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.000642	0.0496	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.000587	0.0454	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.000587	0.0454	CbGpPWpGaD
Bendroflumethiazide—TPMT—Phase II conjugation—SLC26A1—nephrolithiasis	0.000524	0.0406	CbGpPWpGaD
Bendroflumethiazide—Gout—Hydrochlorothiazide—nephrolithiasis	0.00047	0.0619	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.000445	0.0344	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.000413	0.032	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—nephron tubule—nephrolithiasis	0.000409	0.021	CbGeAlD
Bendroflumethiazide—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.000396	0.0523	CcSEcCtD
Bendroflumethiazide—SLC12A3—renal system—nephrolithiasis	0.000372	0.0191	CbGeAlD
Bendroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.000368	0.0285	CbGpPWpGaD
Bendroflumethiazide—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.000366	0.0482	CcSEcCtD
Bendroflumethiazide—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.000362	0.0478	CcSEcCtD
Bendroflumethiazide—SLC12A3—kidney—nephrolithiasis	0.00036	0.0185	CbGeAlD
Bendroflumethiazide—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.000356	0.0469	CcSEcCtD
Bendroflumethiazide—SLC12A3—cortex of kidney—nephrolithiasis	0.00035	0.018	CbGeAlD
Bendroflumethiazide—Thirst—Hydrochlorothiazide—nephrolithiasis	0.000334	0.0441	CcSEcCtD
Bendroflumethiazide—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00033	0.0435	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—SLC26A1—nephrolithiasis	0.000307	0.0237	CbGpPWpGaD
Bendroflumethiazide—TPMT—nephron tubule—nephrolithiasis	0.000304	0.0156	CbGeAlD
Bendroflumethiazide—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000291	0.0383	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00029	0.0382	CcSEcCtD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000287	0.0222	CbGpPWpGaD
Bendroflumethiazide—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.000287	0.0378	CcSEcCtD
Bendroflumethiazide—TPMT—renal system—nephrolithiasis	0.000277	0.0142	CbGeAlD
Bendroflumethiazide—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00027	0.0356	CcSEcCtD
Bendroflumethiazide—TPMT—kidney—nephrolithiasis	0.000267	0.0137	CbGeAlD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000262	0.0203	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000262	0.0203	CbGpPWpGaD
Bendroflumethiazide—TPMT—cortex of kidney—nephrolithiasis	0.00026	0.0134	CbGeAlD
Bendroflumethiazide—KCNMA1—renal system—nephrolithiasis	0.000257	0.0132	CbGeAlD
Bendroflumethiazide—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000253	0.0334	CcSEcCtD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000199	0.0154	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000199	0.0154	CbGpPWpGaD
Bendroflumethiazide—CA1—renal system—nephrolithiasis	0.000196	0.01	CbGeAlD
Bendroflumethiazide—CA1—kidney—nephrolithiasis	0.000189	0.0097	CbGeAlD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000185	0.0143	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000185	0.0143	CbGpPWpGaD
Bendroflumethiazide—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000184	0.0243	CcSEcCtD
Bendroflumethiazide—CA4—nephron tubule—nephrolithiasis	0.000168	0.00863	CbGeAlD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000165	0.0127	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000163	0.0126	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000163	0.0126	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000153	0.0202	CcSEcCtD
Bendroflumethiazide—CA4—renal system—nephrolithiasis	0.000153	0.00785	CbGeAlD
Bendroflumethiazide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000149	0.0197	CcSEcCtD
Bendroflumethiazide—CA4—kidney—nephrolithiasis	0.000148	0.00758	CbGeAlD
Bendroflumethiazide—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000146	0.0193	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000146	0.0113	CbGpPWpGaD
Bendroflumethiazide—CA4—cortex of kidney—nephrolithiasis	0.000144	0.00739	CbGeAlD
Bendroflumethiazide—CA2—nephron tubule—nephrolithiasis	0.000139	0.00716	CbGeAlD
Bendroflumethiazide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000136	0.0179	CcSEcCtD
Bendroflumethiazide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000134	0.0176	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000133	0.0103	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000133	0.0103	CbGpPWpGaD
Bendroflumethiazide—CA2—renal system—nephrolithiasis	0.000127	0.00651	CbGeAlD
Bendroflumethiazide—CA2—kidney—nephrolithiasis	0.000122	0.00629	CbGeAlD
Bendroflumethiazide—CA2—cortex of kidney—nephrolithiasis	0.000119	0.00612	CbGeAlD
Bendroflumethiazide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000112	0.0148	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000107	0.0141	CcSEcCtD
Bendroflumethiazide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000103	0.0136	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000101	0.00781	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000101	0.00781	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Hydrochlorothiazide—nephrolithiasis	9.94e-05	0.0131	CcSEcCtD
Bendroflumethiazide—Rash—Hydrochlorothiazide—nephrolithiasis	9.86e-05	0.013	CcSEcCtD
Bendroflumethiazide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	9.85e-05	0.013	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	9.39e-05	0.00726	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	9.39e-05	0.00726	CbGpPWpGaD
Bendroflumethiazide—Nausea—Hydrochlorothiazide—nephrolithiasis	9.29e-05	0.0123	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—DGKH—nephrolithiasis	9.16e-05	0.00709	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SLC7A9—nephrolithiasis	9.16e-05	0.00709	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	8.37e-05	0.00647	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	8.37e-05	0.00647	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GRHPR—nephrolithiasis	6.92e-05	0.00536	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	6.69e-05	0.00518	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AGXT—nephrolithiasis	6.17e-05	0.00477	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—APRT—nephrolithiasis	5.25e-05	0.00406	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC26A1—nephrolithiasis	5.25e-05	0.00406	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GRHPR—nephrolithiasis	5.01e-05	0.00387	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GRHPR—nephrolithiasis	4.8e-05	0.00371	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GRHPR—nephrolithiasis	4.6e-05	0.00356	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AGXT—nephrolithiasis	4.46e-05	0.00345	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AGXT—nephrolithiasis	4.28e-05	0.00331	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AGXT—nephrolithiasis	4.1e-05	0.00317	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC26A1—nephrolithiasis	3.79e-05	0.00293	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—APRT—nephrolithiasis	3.79e-05	0.00293	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AQP1—nephrolithiasis	3.74e-05	0.00289	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC26A1—nephrolithiasis	3.64e-05	0.00281	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—APRT—nephrolithiasis	3.64e-05	0.00281	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC26A1—nephrolithiasis	3.49e-05	0.0027	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—APRT—nephrolithiasis	3.49e-05	0.0027	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CHRM3—nephrolithiasis	3.38e-05	0.00262	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AQP1—nephrolithiasis	2.7e-05	0.00209	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AQP1—nephrolithiasis	2.59e-05	0.002	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AQP1—nephrolithiasis	2.48e-05	0.00192	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CHRM3—nephrolithiasis	2.44e-05	0.00189	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CHRM3—nephrolithiasis	2.34e-05	0.00181	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CHRM3—nephrolithiasis	2.25e-05	0.00174	CbGpPWpGaD
